Aug 19, 2025 11:27AM
Aug 8, 2025 08:17AM
Jul 14, 2025 09:56AM
Jun 17, 2025 06:04AM
Jun 4, 2025 05:10AM
May 8, 2025 04:49PM
May 7, 2025 06:00AM PTC Therapeutics (PTCT) PT Lowered to $42 at Barclays
May 7, 2025 03:35AM
May 6, 2025 04:01PM
Apr 25, 2025 09:00AM
Apr 25, 2025 09:00AM
Feb 19, 2025 10:31AM
Feb 19, 2025 07:01AM
Feb 19, 2025 07:00AM PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia
Jan 13, 2025 12:50PM
Oct 30, 2024 07:00AM
Oct 30, 2024 07:00AM
Oct 15, 2024 05:42AM
Oct 1, 2024 09:05AM
Oct 1, 2024 09:00AM
Aug 9, 2024 02:10PM PTC Therapeutics (PTCT) PT Raised to $33 at TD Cowen
May 14, 2024 07:30AM
May 14, 2024 07:30AM
Sep 15, 2023 12:50PM
Sep 13, 2021 08:00AM
Aug 5, 2020 04:01PM
Jul 20, 2020 07:45AM
Jul 20, 2020 07:45AM Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
Jul 20, 2020 07:31AM
Jul 20, 2020 07:30AM
Apr 30, 2020 05:22PM
Apr 30, 2020 04:01PM
Apr 28, 2020 01:00AM
Apr 7, 2020 04:08PM
Apr 7, 2020 04:05PM PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)
Mar 2, 2020 04:01PM
Feb 20, 2020 04:55AM
Feb 6, 2020 06:17AM
Feb 6, 2020 05:00AM
Jan 23, 2020 06:20AM
Jan 23, 2020 01:00AM
Jan 13, 2020 08:07AM PTC Therapeutics (PTCT) anticipates FY20 net product revenues for DMD franchise to be between $320 and $340 million
Jan 13, 2020 08:00AM
Nov 25, 2019 06:19AM
Nov 25, 2019 01:00AM
Sep 18, 2019 09:26AM
Aug 7, 2018 04:01PM
Aug 2, 2018 08:00AM
Oct 9, 2017 03:50AM JPMorgan Downgrades PTC Therapeutics (PTCT) to Underweight Citing Mixed Updates and Valuation
Sep 29, 2017 09:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All